NCT07636161SuspendedPhase 4
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon): A Pilot Randomized Trial of Eroxon® Gel as an Adjunct to Tadalafil in Young Men With Diabetes-Associated Erectile Dysfunction
Source: ClinicalTrials.gov · Last updated 28 Sept 2026
Reason given: The sponsor has communicated that they may no longer fund this research study. Pending final confirmation if the study will be closed.
Brief summary (registry, in English)
The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.
- Status (registry)
- Suspended
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 3 Jun 2026
- Start date
- Oct 2026
- Primary completion date
- Sept 2027
- Lead sponsor
- University of Miami
- Diseases
- Type 2 diabetes
- NCT number
- NCT07636161
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Type 1 diabetes mellitus
- Severe psychiatric illness that would impair participation
- Known allergy to Eroxon® gel components
Other
- Use of nitrates or contraindications to sexual activity
- Participation in another interventional sexual health study
Who the study is looking for
- Male sex at birth
- Age 18-40 years
- Diagnosis of type 2 diabetes mellitus
- Diagnosis of erectile dysfunction
- Currently prescribed tadalafil
- Have a sexual partner willing to complete a survey
- Ability to provide informed consent
Age in the registry: 18 years to 40 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Don Soffer Clinical Research Building | Miami | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.